<didl:DIDL xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xmlns:dcterms="http://purl.org/dc/terms/" DIDLDocumentId="http://crdd.osdd.net/open/id/eprint/3487" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>http://crdd.osdd.net/open/id/eprint/3487</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-07-22T01:03:53Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="http://crdd.osdd.net/open/cgi/export/eprint/3487/DIDL/open-eprint-3487.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:title>Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate</dc:title>
        <dc:creator>Srivastava, Simran</dc:creator>
        <dc:creator>Kumar, Sahil</dc:creator>
        <dc:creator>Mishra, Suman</dc:creator>
        <dc:creator>Rajmani, Raju S</dc:creator>
        <dc:creator>Singh, Randhir</dc:creator>
        <dc:creator>Dutta, Somnath</dc:creator>
        <dc:creator>Ringe, Rajesh Prakash</dc:creator>
        <dc:creator>Varadarajan, Raghavan</dc:creator>
        <dc:subject>QR Microbiology</dc:subject>
        <dc:description>Zoonotic spillover of sarbecoviruses to humans resulted in the SARS-CoV-1 outbreak in 2003 and the current COVID-19 pandemic caused by SARS-CoV-2. In both cases, the viral spike protein (S) is the principal target of neutralizing antibodies that prevent infection. Within the spike, the immunodominant receptor-binding domain (RBD) is the primary target of neutralizing antibodies in COVID-19 convalescent sera and vaccine recipients. We have constructed stabilized RBD derivatives of different sarbecoviruses: SARS-CoV-1 (Clade 1a), WIV-1 (Clade 1a), RaTG13 (Clade 1b), RmYN02 (Clade 2), and BtKY72 (Clade 3). Stabilization enhanced yield by 3-23-fold. The RBD derivatives were conformationally intact, as assayed by binding to multiple broadly neutralizing antibodies. The stabilized RBDs show significant enhancement in apparent Tm, exhibit resistance to a 2-h incubation at temperatures up to 60 Â°C in PBS in contrast to the corresponding WT RBDs, and show prolonged stability of over 15 days at 37 Â°C after lyophilization. In mice immunizations, both stabilization and trimerization significantly enhanced elicited neutralization titers by â�¼100-fold. The stabilized RBD cocktail elicited highly neutralizing titers against both homologous and heterologous pseudoviruses. The immunogenicity of the vaccine formulation was assessed in both na\"\ive and SARS-CoV-2 preimmunized mice, revealing an absence of immune imprinting, thus indicating its suitability for use in future sarbecovirus-origin epidemics or pandemics.</dc:description>
        <dc:publisher>American Chemical Society (ACS)</dc:publisher>
        <dc:date>2026-01-09</dc:date>
        <dc:type>Article</dc:type>
        <dc:type>PeerReviewed</dc:type>
        <dc:format>text/html</dc:format>
        <dc:identifier>http://crdd.osdd.net/open/3487/1/references.bib</dc:identifier>
        <dc:relation>https://pmc.ncbi.nlm.nih.gov/articles/PMC12797234/</dc:relation>
        <dc:identifier>  Srivastava, Simran and Kumar, Sahil and Mishra, Suman and Rajmani, Raju S and Singh, Randhir and Dutta, Somnath and Ringe, Rajesh Prakash and Varadarajan, Raghavan  (2026) Development of a thermostable and broadly neutralizing pan-sarbecovirus vaccine candidate.  ACS Infect. Dis., 12 (1).  pp. 104-118.      </dc:identifier>
        <dc:relation>http://crdd.osdd.net/open/3487/</dc:relation></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/objectFile</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="text/html" ref="http://crdd.osdd.net/open/3487/1/references.bib"/>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/html" ref="http://crdd.osdd.net/open/3487/"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>